Favoritism in DNA methylation

Cancer Prevention Research

Volumn 2, Issue 10, 2009, Pages 847-849

  Hitchins, Megan P ^a   Ward, Robyn L ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE;

CANCER PREVENTION; CANCER SCREENING; CANCER SUSCEPTIBILITY; CHEMOPROPHYLAXIS; DNA METHYLATION; DNA SEQUENCE; EPIGENETICS; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MALIGNANT NEOPLASTIC DISEASE; PRIORITY JOURNAL; REVIEW;

ANIMALS; DNA METHYLATION; DNA MODIFICATION METHYLASES; DNA REPAIR ENZYMES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; NEOPLASMS; TUMOR SUPPRESSOR PROTEINS;

EID: 70449433474     PISSN: 19406207     EISSN: None     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-09-0178     Document Type: Review

References (22)

1. Glenn CC, Nicholls RD, Robinson WP, et al. Modification of 15q11-13 DNA methylation imprints in unique Angelman and Prader-Willi patients. Hum Mol Genet 1993;2:1377-1382 (Pubitemid 23271180)
2. Brown KW, Villar AJ, Bickmore W, et al. Imprinting mutation in the Beckwith-Wiedemann syndrome leads to biallelic IGF2 expression through an H19- independent pathway. Hum Mol Genet 1996;5: 2027-2032 (Pubitemid 26413650)
3. Wang YH. Chromatin structure of repeating CTG/ CAG and CGG/CCG sequences in human disease. Front Biosci 2007;12:4731-4741
4. Tufarelli C, Stanley JA, Garrick D, et al. Transcription of antisense RNA leading to gene silencing and methylation as a novel cause of human genetic disease. Nat Genet 2003;34:157-165 (Pubitemid 36666926)
5. Ligtenberg MJ, Kuiper RP, Chan TL, et al. Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1. Nat Genet 2009;41: 112-117
6. Raval A, Tanner SM, Byrd JC, et al. Downregulation of death-associated protein kinase 1 (DAPK1) in chronic lymphocytic leukemia. Cell 2007;129: 879-890 (Pubitemid 46813150)
7. Plenge RM, Hendrich BD, Schwartz C, et al. A promoter mutation in the XIST gene in two unrelated families with skewed X-chromosome inactivation. Nat Genet 1997;17:353-356 (Pubitemid 27476005)
8. Tomkins DJ, McDonald HL, Farrell SA, Brown CJ. Lack of expression of XIST from a small ring X chromosome containing the XIST locus in a girl with short stature, facial dysmorphism and developmental delay. Eur J Hum Genet 2002; 10:44-51.
9. Pugacheva EM, Tiwari VK, Abdullaev Z, et al. Familial cases of point mutations in the XIST promoter reveal a correlation between CTCF binding and pre-emptive choices of X chromosome inactivation. Hum Mol Genet 2005;14:953-965 (Pubitemid 40533106)
10. Candiloro ILM, Dobrovic A. Detection of MGMT promoter methylation in normal individuals is strongly associated with the T allele of the rs16906252 MGMT promoter single nucleotide polymorphism. Cancer Prev Res 2009;2:862-867
11. Esteller M, Toyota M, Sanchez-Cespedes M, et al. Inactivation of the DNA repair gene O6- methylguanine-DNA methyltransferase by promoter hypermethylation is associated with G to A mutations in K-ras in colorectal tumorigenesis. Cancer Res 2000;60:2368-2371 (Pubitemid 30262424)
12. Casorelli I, Russo MT, Bignami M. Role of mismatch repair and MGMT in response to anticancer therapies. Anticanc Agents Med Chem 2008;8: 368-380 (Pubitemid 351761422)
13. Ogino S, Hazra A, Tranah GJ, et al. MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer. Carcinogenesis 2007;28:1985-1990 (Pubitemid 47514483)
14. Hawkins N, Lee J, Wong J, Ward R, Hitchins M. MGMT methylation is associated primarily with the germline C>T SNP (rs16906252) in colorectal cancer and normal colonic mucosa. Mod Pathol, In press 2009.
15. Shen L, Kondo Y, Rosner GL, et al. MGMT promoter methylation and field defect in sporadic colorectal cancer. J Natl Cancer Inst 2005;97: 1330-1338 (Pubitemid 41487800)
16. Menigatti M, Pedroni M, Verrone AM, et al. O6- methylguanine-DNA methyltransferase promoter hypermethylation in colorectal carcinogenesis. Oncol Rep 2007;17:1421-1427
17. Ye C, Shrubsole MJ, Cai Q, et al. Promoter methylation status of the MGMT, hMLH1, and CDKN2A/ p16 genes in non-neoplastic mucosa of patients with and without colorectal adenomas. Oncol Rep 2006;16:429-435
18. Slaughter DP, Southwick HW, Smejkal W. Field cancerization in oral stratified squamous epithelium;cllnical implications of multicentric origin. Cancer 1953;6:963-968
19. Harris LC, Remack JS, Brent TP. Identification of a 59 bp enhancer located at the first exon/intron boundary of the human O6-methylguanine DNA methyltransferase gene. Nucleic Acids Res 1994;22:4614-4619
20. Chen FY, Hams LC, Remack JS, Brent TP. Cytoplasmic sequestration of an O6-methylguanine- DNA methyltransferase enhancer binding protein in DNA repair-deficient human cells. Proc Natl Acad Sci U S A 1997;94:4348-4353
21. Oyer JA, Chu A, Brar S, Turker MS. Aberrant epigenetic silencing is triggered by a transient reduction in gene expression. PLoS One 2009;4:e4832.
22. Thomas S, Munster PN. Histone deacetylase inhibitor induced modulation of anti-estrogen therapy. Cancer Lett 2009;280:184-191